Target- |
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Dec 1989 |
100 Clinical Results associated with Jubilant Pharmaceuticals, Inc.
0 Patents (Medical) associated with Jubilant Pharmaceuticals, Inc.
100 Deals associated with Jubilant Pharmaceuticals, Inc.
100 Translational Medicine associated with Jubilant Pharmaceuticals, Inc.